LexDanaLexDanabeta
Inventor

Sachdev S. Sidhu

Inventor
Toronto, CA

Overview

42→
Patents
2006–2021
Patent span
Chemistry
Primary field (CPC C)

Patents· 42 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Kprimary
C07KPeptides30%
A61KPreparations for medical, dental or toiletry purposes21%
G01NInvestigating or analysing materials by determining their chemical or physical properties20%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations14%
C12NMicroorganisms or enzymes6%
C40BCombinatorial chemistry4%
C12YEnzymes3%
C07HSugars2%
Y02ATechnologies for adaptation to climate change1%
PatentTitleYear
11,124,575EGFR-binding agents and uses thereof202110,875,907Filovirus antibody202010,808,017Ubiquitin variants and uses therof as 53BP1 inhibitors202010,759,851Synthetic antibodies to BAX and uses thereof202010,746,743Molecular display system202010,697,963Nucleic acids encoding antibodies with high affinity for Alpha-Klotho202010,689,442Antibodies against Frizzled receptor202010,663,474Antibodies which specifically bind aKlotho polypeptide202010,618,943Ubiquitin variant modulators of HECT E3 ligases and their uses202010,618,942Ubiquitin variant modulators of SCF E3 ligases and their uses202010,562,945Specific active site inhibitors of enzymes or substrate binding partners and methods of producing same202010,481,162Protein sequencing method and reagents201910,435,461Therapy for filovirus infection201910,294,294Synthetic antibodies to BAX and uses thereof201910,274,499SH2 domain variants201910,228,374Antibodies with high affinity for alpha-Klotho201910,214,570Specific active site inhibitors of enzymes and methods of producing same201910,093,921Scaffolded peptidic libraries and methods of making and screening the same201810,081,669Therapy for filovirus infection201810,077,304Antibodies against frizzled receptor20189,566,335'Protein sequencing method and reagents'20179,353,177'Anti-VEGF antibodies'20169,346,875'Therapy for filovirus infection'20169,285,372'Methods and compositions for identifying D-peptidic compounds that specifically bind target proteins'20169,234,024'Affinity matured CRIg variants'20169,018,357'Anti-VEGF antibodies'20158,975,381'Anti-VEGF antibodies'20158,957,187'Binding polypeptides and uses thereof'20158,685,893'Phage display'20148,512,699'Anti-VEGF antibodies'20138,492,527'Anti-VEGF antibodies'20138,101,177'Anti-VEGF antibodies'20128,092,797'Anti-VEGF antibodies'20127,985,840'Synthetic antibody phage libraries'20117,977,064'Disheveled PDZ modulators'20117,811,785'Anti-VEGF antibodies'20107,785,903'Variable domain library and uses'20107,758,859'Anti-VEGF antibodies'20107,695,928'Disheveled PDZ modulators'20107,691,977'Anti-VEGF antibodies'20107,432,244'Method of inhibiting insulin-like growth factor-1 (IGF-1) by IGF-1-antagonist peptides'20087,071,300'IGF antagonist peptides'2006

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2006–2016Patents assigned to GENENTECH INC (19)· patent assignee history
2006–2016Based in San Francisco, CA, US· patent location history
2011–2021Based in Toronto, CA· patent location history
2012–2017Patents assigned to SIDHU SACHDEV S (9)· patent assignee history
2012–2016Patents assigned to WIESMANN CHRISTIAN (5)· patent assignee history
2017–2021Patents assigned to GOVERNING COUNCIL UNIV TORONTO (20)· patent assignee history
2019–2020Patents assigned to ALBERT EINSTEIN COLLEGE MEDICINE (4)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
GOVERNING COUNCIL UNIV TORONTO202017–2021
GENENTECH INC192006–2016
SIDHU SACHDEV Sself92012–2017
WIESMANN CHRISTIAN52012–2016
ALBERT EINSTEIN COLLEGE MEDICINE42019–2020
Locations
LocationPatentsSpan
Toronto, CA262011–2021
San Francisco, California, US162006–2016